TABLE 4.
Characteristics of the U.S. clients entering treatment as reported on TEDS: 2007*
| Heroin | Illicit methadone | Other opiates* | |
|---|---|---|---|
| n | 246,871 | 5,094 | 85,422 |
| Percentage male | 69 | 53 | 54 |
| Percentage White | 52 | 85 | 89 |
| Percentage Black | 22 | 6 | 4 |
| Percentage Hispanic | 23 | 7 | 4 |
| Percentage entering treatment at age 35+ | 55 | 40 | 36 |
| Percentage began use at age 18–20 | 24 | 17 | 20 |
| Percentage use daily | 71 | 67 | 62 |
| Percentage reporting current IV use | 64 | 15 | 14 |
| Percentage first admissions | 23 | 39 | 43 |
| Percentage referred by criminal justice | 12 | 15 | 16 |
| Percentage self-referred | 64 | 50 | 51 |
| Percentage homeless | 19 | 6 | 6 |
| Percentage employed | 16 | 27 | 29 |
| Percentage < GED or year 12 completed | 63 | 67 | 75 |
| Percentage with psychiatric problem | 37 | 33 | 25 |
| Percentage with no health insurance† | 55 | 60 | 55 |
Includes codeine, hydrocodone, hydromorphone, meperidine, morphine, opium, oxycodone, pentazocine, propoxyphene, tramadol, and other drugs with morphine-like effects. Nonprescription methadone excluded.
Health insurance included private, medicaid, medicare/tricare.
TEDS data run 16 April, 2009.